Simultaneous quantification of levofloxacin, pefloxacin, ciprofloxacin and moxifloxacin in microvolumes of human plasma using high-performance liquid chromatography with ultraviolet detection
© 2019 John Wiley & Sons, Ltd..
Levofloxacin, pefloxacin, ciprofloxacin and moxifloxacin are four fluoroquinolones used in the treatment of serious bacterial infections. The antibacterial activity of fluoroquinolones is concentration dependent. Therefore, therapeutic drug monitoring in daily clinical practice is warranted to ensure the therapy's efficacy and prevent bacterial resistance. The purpose of the present study was to develop a method using high-pressure liquid chromatography with an ultraviolet detector for simultaneous quantification of these four fluoroquinolones in human plasma. A 50 μL aliquot of plasma was precipitated by 200 μL of methanol using gatifloxacin as internal standard. The chromatographic separation was performed on a Kinetex XB-C18 column using a mobile phase composed of a mixture of orthophosphoric acid 0.4% (v/v), acetonitrile and methanol at a flow rate of 1.2 mL/min. Dual UV wavelength mode was used, with levofloxacin and moxifloxacin monitored at 293 nm, and pefloxacin and ciprofloxacin monitored at 280 nm. The calibration was linear over the ranges of 0.125-25 mg/L for levofloxacin, 0.1-20mg/L for moxifloxacin and 0.05-10 mg/L for both pefloxacin and ciprofloxacin. Inter- and intra-day trueness and precision were <13% for all the compounds under study. The proposed method was simple, reliable, cost-effective and suitable for therapeutic drug monitoring or pharmacokinetics studies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Biomedical chromatography : BMC - 33(2019), 5 vom: 19. Mai, Seite e4506 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zheng, Yi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ciprofloxacin |
|---|
| Anmerkungen: |
Date Completed 06.05.2019 Date Revised 06.05.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/bmc.4506 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM293691290 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM293691290 | ||
| 003 | DE-627 | ||
| 005 | 20231225075851.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/bmc.4506 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0978.xml |
| 035 | |a (DE-627)NLM293691290 | ||
| 035 | |a (NLM)30743308 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zheng, Yi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Simultaneous quantification of levofloxacin, pefloxacin, ciprofloxacin and moxifloxacin in microvolumes of human plasma using high-performance liquid chromatography with ultraviolet detection |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.05.2019 | ||
| 500 | |a Date Revised 06.05.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2019 John Wiley & Sons, Ltd. | ||
| 520 | |a Levofloxacin, pefloxacin, ciprofloxacin and moxifloxacin are four fluoroquinolones used in the treatment of serious bacterial infections. The antibacterial activity of fluoroquinolones is concentration dependent. Therefore, therapeutic drug monitoring in daily clinical practice is warranted to ensure the therapy's efficacy and prevent bacterial resistance. The purpose of the present study was to develop a method using high-pressure liquid chromatography with an ultraviolet detector for simultaneous quantification of these four fluoroquinolones in human plasma. A 50 μL aliquot of plasma was precipitated by 200 μL of methanol using gatifloxacin as internal standard. The chromatographic separation was performed on a Kinetex XB-C18 column using a mobile phase composed of a mixture of orthophosphoric acid 0.4% (v/v), acetonitrile and methanol at a flow rate of 1.2 mL/min. Dual UV wavelength mode was used, with levofloxacin and moxifloxacin monitored at 293 nm, and pefloxacin and ciprofloxacin monitored at 280 nm. The calibration was linear over the ranges of 0.125-25 mg/L for levofloxacin, 0.1-20mg/L for moxifloxacin and 0.05-10 mg/L for both pefloxacin and ciprofloxacin. Inter- and intra-day trueness and precision were <13% for all the compounds under study. The proposed method was simple, reliable, cost-effective and suitable for therapeutic drug monitoring or pharmacokinetics studies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a HPLC-UV | |
| 650 | 4 | |a TDMpefloxacin | |
| 650 | 4 | |a ciprofloxacin | |
| 650 | 4 | |a levofloxacin | |
| 650 | 4 | |a moxifloxacin | |
| 650 | 7 | |a Fluoroquinolones |2 NLM | |
| 700 | 1 | |a Wang, Ziqing |e verfasserin |4 aut | |
| 700 | 1 | |a Lui, Gabrielle |e verfasserin |4 aut | |
| 700 | 1 | |a Hirt, Déborah |e verfasserin |4 aut | |
| 700 | 1 | |a Treluyer, Jean-Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Benaboud, Sihem |e verfasserin |4 aut | |
| 700 | 1 | |a Aboura, Radia |e verfasserin |4 aut | |
| 700 | 1 | |a Gana, Inès |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomedical chromatography : BMC |d 1987 |g 33(2019), 5 vom: 19. Mai, Seite e4506 |w (DE-627)NLM012669806 |x 1099-0801 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2019 |g number:5 |g day:19 |g month:05 |g pages:e4506 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/bmc.4506 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2019 |e 5 |b 19 |c 05 |h e4506 | ||